Saturday, June 10, 2023 4:22:55 PM
OJ,
I'll agree with you that Dr. Bosch's presentation wasn't peer reviewed, but I do believe he showed some scientific information that hadn't ever been shown before, and it was important. I believe he said more about T-cells than any presentation I can remember in the past and the graphics involved were excellent.
I really don't believe anyone outside of the company and regulators they've been speaking with know how close we are to filing for approvals. They could come Monday, or not for months, we just don't know. They could file with just the UK, or all four regulators together, only they know what they intend to do.
I'm like many others here, willing to speculate as to what they may do, but it's just that, speculation. When they do something, or perhaps say something, we'll know more than we do today. Until then we're all free to be as positive, or negative as we wish to be.
I believe the gradual share price growth recently is an indication that new investors are learning of NWBO and getting in. The higher our price goes before news the better IMHO. Without further news I'd not be surprised if we see $1 or more by the end of June, with any positive news it could go much higher than that. Some may say it's dead money for this year, but a close this year above $1 is roughly double my investment, and I think that's true for many others, very few of my friends wouldn't be thrilled by their investments being worth twice what they paid in a matter of a few years.
Gary
I'll agree with you that Dr. Bosch's presentation wasn't peer reviewed, but I do believe he showed some scientific information that hadn't ever been shown before, and it was important. I believe he said more about T-cells than any presentation I can remember in the past and the graphics involved were excellent.
I really don't believe anyone outside of the company and regulators they've been speaking with know how close we are to filing for approvals. They could come Monday, or not for months, we just don't know. They could file with just the UK, or all four regulators together, only they know what they intend to do.
I'm like many others here, willing to speculate as to what they may do, but it's just that, speculation. When they do something, or perhaps say something, we'll know more than we do today. Until then we're all free to be as positive, or negative as we wish to be.
I believe the gradual share price growth recently is an indication that new investors are learning of NWBO and getting in. The higher our price goes before news the better IMHO. Without further news I'd not be surprised if we see $1 or more by the end of June, with any positive news it could go much higher than that. Some may say it's dead money for this year, but a close this year above $1 is roughly double my investment, and I think that's true for many others, very few of my friends wouldn't be thrilled by their investments being worth twice what they paid in a matter of a few years.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
